Acorn Energy to Host Investor Conference Call on Thursday, November 12, 2009 at 4:15 pm ET
|
| Posted
:
Mon, 09 Nov 2009 19:10:41 GMT |
| Author
:
Acorn Energy, Inc. |
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
|
|
|
|
MONTCHANIN, Del., Nov. 9 /PRNewswire-FirstCall/ -- Acorn Energy, Inc. (Nadsaq: ACFN) today announced that John A. Moore, Chairman of the Board and CEO of Acorn Energy, will host an investor call on Thursday, November 12th at 4:15 pm ET to discuss its third quarter 2009 results and developments at the Company. The Company will release financial results for the third quarter before the market opens on November 12th.
To participate in the conference call, please dial (800) 860-2442 or (412) 858-4600 (Intl) (no pass code required). You may also access the call through the Internet at www.acornenergy.com. If you are unable to participate in the live call, a digital replay of the call will be available through 9:00 AM on November 27, 2009 by dialing (877) 344-7529 or (412) 317-0088 and entering account # 435680.
About Acorn Energy, Inc.
Acorn Energy, Inc. is a publicly traded holding company with equity interests in CoaLogix, Coreworx, DSIT and GridSense. These companies leverage advanced technologies to transform and upgrade the energy infrastructure around the world. Acorn companies are focused on three problems in the energy sector: improving the efficiency of the energy grid, reducing the risk for owners of large energy assets, and reducing the environmental impact of the energy sector. Acorn's strategy is to take primarily controlling positions in companies led by great entrepreneurs. For more information visit http://www.acornenergy.com
Safe Harbor Statement
This press release includes forward-looking statements, which are subject to risks and uncertainties. There is no assurance that CoaLogix, DSIT, Coreworx or GridSense will continue to grow their respective businesses. A complete discussion of the risks and uncertainties which may affect Acorn Energy's business generally is included in "Risk Factors" in the Company's most recent Annual Report on Form 10-K as filed by the Company with the Securities and Exchange Commission.
Investor Contact:
Paul G. Henning
Cameron Associates
(212) 554-5462
Paul@cameronassoc.com
SOURCE Acorn Energy, Inc.
|
Copyright © 2008
PR Newswire. All rights reserved.
|
|
|
|
|
Related
News
GoldenSource Market Leadership Recognised in Financial News Tech21 List
LONDON, November 23 /PRNewswire/ -- GoldenSource has been recognised as a
leading innovator in financial markets technology by Financial News in its
4th annual Tech 21 list of innovators and market leaders for the 21st century.
GoldenSource wa...
Advanced ID Corp. Completes Repayment of La Jolla Cove Funding CALGARY, AB -- 11/23/09 --
Advanced ID Corporation (OTCBB: AIDO) a
leading developer of RFID solutions for supply chain applications, fleet
operations, animal tracking and tire management announces today that it has
fulfilled the terms of the Sept..
Research and Markets: 2009 Plimsoll Analysis - Abnormal Load Haulage - a Comprehensive Profile of 80 Companies Operating in the UK Market DUBLIN -
Research and Markets (
Aesthetic Plastic Surgery: The Next Generation Symposium Launches in NYC NEW YORK -
Aesthetic Plastic Surgery: The Next Generation Symposium will be held
from December 4-6 at the Waldorf Astoria, announces Z. Paul Lorenc, MD,
FACS, New York aesthetic plastic surgeon and Chairman of the APSSNY.
The CME-accredited three-day interactive conference, h
MedPro Safety Products Reports Recent Progress LEXINGTON, Ky. -
MedPro Safety Products, Inc. (OTCBB: MPSP), a pioneer in the development
and marketing of passive needlestick injury prevention technology, today
reported on the Company’s recent progress.
The recent highlights include:
Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain
NOVATO, Calif., Nov. 23 -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP) today announced the presentation of clinical trial data on NGX426, the Company's orally administered, non-opioid, AMPA/kainate receptor antagonist...
AngioDynamics to Participate in the 21st Annual Piper Jaffray Health Care Conference QUEENSBURY, N.Y. -
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical
devices for the minimally-invasive treatment of cancer and peripheral
vascular disease, announced today that it will present at the 21st
Annual Piper Jaffray Health Care Conference in New York
|
|
|
|
|
|
|
|
|